Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome (NEOSURF)
Sponsor: University of Missouri-Columbia
Listed as NCT02834624, this NA trial focuses on Respiratory Distress Syndrome and remains completed. Sponsored by University of Missouri-Columbia, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jul 2017 — Jun 2018 [monthly]
Completed NA
-
Feb 2017 — Jul 2017 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Missouri-Columbia
For direct contact, visit the study record on ClinicalTrials.gov .